UBI Stock Overview
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia.
Universal Biosensors, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.24|
|52 Week High||AU$1.04|
|52 Week Low||AU$0.22|
|1 Month Change||0%|
|3 Month Change||-18.64%|
|1 Year Change||-71.08%|
|3 Year Change||14.29%|
|5 Year Change||-20.00%|
|Change since IPO||-76.00%|
Recent News & Updates
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn RateOct 10
Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In GrowthApr 28
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business GrowthMay 13
Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?Feb 24
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business GrowthJan 20
The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For MoreDec 15
|UBI||AU Medical Equipment||AU Market|
Return vs Industry: UBI underperformed the Australian Medical Equipment industry which returned -7.5% over the past year.
Return vs Market: UBI underperformed the Australian Market which returned -2.2% over the past year.
|UBI Average Weekly Movement||11.7%|
|Medical Equipment Industry Average Movement||10.1%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.9%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: UBI is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: UBI's weekly volatility (12%) has been stable over the past year.
About the Company
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens’ Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin.
Universal Biosensors, Inc. Fundamentals Summary
|UBI fundamental statistics|
Is UBI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|UBI income statement (TTM)|
|Cost of Revenue||AU$3.07m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.088|
|Net Profit Margin||-373.23%|
How did UBI perform over the long term?See historical performance and comparison